Ideas to action: independent research for global prosperity
A Litany of Market Failures: Diagnosing and Solving the Economic Drivers of Antibiotic Resistance
February 22, 2024
The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve antibiotic resistance, it’s not enough to solve just some of these. If we fix the market failures that reduce the number of new antibiotics that are discovered, but not t...
The Economics of Antibiotic Resistance
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
Five Proposals for a New Era in UK Global Health Policy
September 27, 2023
The UK is, hopefully, coming out of its nadir in international development. This is marked by planned rises in development spend, an ambitious new international development white paper, a supportive Minister, and a new parliament in 2024. But before considering any proposal, future governments with ...
Six Recommendations to Improve the Market for Antimicrobials
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
A New Grand Bargain to Improve the Antimicrobial Market for Human Health
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
9:00—10:00 AM ET / 2:00-3:00 PM BST
Six Recommendations to Improve the Antimicrobial Market for Human Health
September 18, 2023
This discussion will focus on next steps to implement policy recommendations and build consensus on collective priorities in the lead-up to next year’s United Nations General Assembly High-Level Meeting on antimicrobial resistance—a key opportunity to set priorities and accelerate policy change.
6:30—8:00 PM ET, Sixth Floor Loft 873 Broadway, Sixth Floor New York, NY 10003
A Path Towards Affordable and Effective Antimicrobials: Six Recommendations to Improve Antimicrobial Innovation, Access, and Stewardship
August 10, 2023
The silent pandemic of antimicrobial resistance (AMR) is an urgent health crisis. Fixing the antimicrobial market to ensure adequate innovation, access, and stewardship is a key lever in the fight against AMR, especially to address the disproportionate burden of AMR in low- and middle-income countri...
Overcoming Barriers to Improve Antimicrobial Access, Innovation, and Stewardship in India
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
CGD in the News
Antimicrobial resistance to cause 5.2 million deaths in western Pacific by 2030, new report says
June 13, 2023
Leveraging Brazilian Leadership and Procurement Arrangements in the Fight Against Antimicrobial Resistance
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...